HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marjut Niinivirta Selected Research

Renal Cell Carcinoma (Grawitz Tumor)

4/2020Tumor endothelial ELTD1 as a predictive marker for treatment of renal cancer patients with sunitinib.
1/2019Tumoral Pyruvate Kinase L/R as a Predictive Marker for the Treatment of Renal Cancer Patients with Sunitinib and Sorafenib.
6/2017Tumoral cubilin is a predictive marker for treatment of renal cancer patients with sunitinib and sorafenib.
1/2017Tumoral ANXA1 Is a Predictive Marker for Sunitinib Treatment of Renal Cancer Patients.
1/2017A systematic search strategy identifies cubilin as independent prognostic marker for renal cell carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marjut Niinivirta Research Topics

Disease

5Renal Cell Carcinoma (Grawitz Tumor)
04/2020 - 01/2017
4Kidney Neoplasms (Kidney Cancer)
04/2020 - 01/2017
2Neoplasms (Cancer)
04/2020 - 06/2017

Drug/Important Bio-Agent (IBA)

4Sunitinib (Sutent)FDA Link
04/2020 - 01/2017
4Tyrosine Kinase InhibitorsIBA
04/2020 - 01/2017
2Proteins (Proteins, Gene)FDA Link
04/2020 - 06/2017
2Sorafenib (BAY 43-9006)FDA Link
01/2019 - 06/2017
2intrinsic factor-cobalamin receptorIBA
06/2017 - 01/2017
1Biomarkers (Surrogate Marker)IBA
04/2020
1alpha-latrotoxin receptorIBA
04/2020
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2020
1Epidermal Growth Factor (EGF)IBA
04/2020
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
04/2020
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
04/2020
1Pyruvate KinaseIBA
01/2019